Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
株式のランク #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
株価
$0.00185055
時価総額
$48.29K
変化(1日)
-3.55%
変化(1年)
30.31%
GB
取引 Nuformix plc (NFX)

カテゴリー

Nuformix plc(NFX)の配当利回りの履歴
Nuformix plc(銘柄コード: NFX)の配当利回り(TTM)は2024-09-30時点で0.00%です。
過去5年間の平均配当利回り: 0.00%
Nuformix plc(NFX)の2014から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2014 0.00% 0.00%
類似企業または競合他社の配当利回り(TTM)